Clinical Trial Update: Metformin Efficacy and Safety for Gastric Intestinal Metaplasia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating metformin for gastric intestinal metaplasia has completed, reporting on its efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Intestinal Metaplasia

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Xijing Hospital of Digestive Diseases | Conditions: Gastric Intestinal Metaplasia | Phase 4 | Status: COMPLETED